The nascent CBD industry is trying to work through the kinks at the same time demand is ramping up, leaving producers frustrated and consumers with unreliable products. » Read More
By: Christina Farr
Doctors feel that taking metformin is mostly safe, but cautioned about the lack of clinical studies. » Read More
Biogen and Eisai lost billions of dollars in market value after halting two late-stage trials of a promising experimental Alzheimer's drug. » Read More
By: Jane Wells
The maker of the premature ejaculation drug Promescent is suing consumer giant Reckitt Benckiser for $150 million, alleging fraud and theft of trade secrets. » Read More
The game theory comes in with the timing of when new rules might be adopted. Executives note the deadline for filing 2020 plans is in early June.
The news comes as the actor launched "SameYou", a charity aiming to offer treatment to those recovering from stroke and brain injury.
Former Aetna Chairman and CEO Mark Bertolini says investors currently are trading "on a basis that says, 'does this drug work today? Did this trial pass today?''"
FDA chief Gottlieb leaves his post as the agency wages a pitched battle against teen smoking and tackles complex CBD regulations.
To win big pharmaceutical advertisers, Snap is positioning itself as a friendlier social network than Facebook and Twitter.
Eisai said it has begun phase 3 clinical trials of Alzheimer's treatment, a day after the Japanese drugmaker and U.S. partner Biogen scrapped trials for its own Alzheimer's drug.
The study shows how sugar drives tumor growth, possibly explaining a surge in early colon cancer diagnoses in young adults.
Rite Aid shareholders have approved the company's reverse stock split, the company announced Thursday, a move aimed at keeping the drugstore chain's shares trading on New York Stock Exchange.
CVS has started selling CBD, short for cannabidiol products, in eight states. CEO Larry Merlo said CVS will "walk slowly."
Jim Cramer reveals why Nike is an ideal investment that can do well with or without a trade deal.
The pharmacy chain said the products include topicals such as creams, sprays, roll-ons, lotions and salves.
Certain medications commonly used to treat ADHD in teens and young adults may increase their risk of psychosis, according to researchers at Harvard Medical School and McLean Hospital.
Ro, the men's health start-up known for straight-to-your-door erectile dysfunction medication, is launching a new service targeting women.
Pfizer Inc said on Wednesday it has acquired a 15 percent stake in Vivet Therapeutics, and has an exclusive option to fully acquire the privately held French company that develops gene therapies for liver disorders.
A U.S. jury on Tuesday found Bayer AG's glyphosate-based weed killer to be a "substantial factor" in causing a man's non-Hodgkin's lymphoma, allowing the trial to proceed into a second phase on liability and damages.
The Brazilian butt lift was the hottest growing segment, surging 19 percent with more than 24,000 procedures last year, plastic surgeons say.